Navigation Links
Determine HBsAg - Serum & Blood

ProductsDetermine HBsAg - Serum & Blood
Company Inverness Medical Professional Diagnostics
Item Determine HBsAg - Serum & Blood
Features Accessories
  • Chase Buffer (7D22-11)
  • Disposable pipettes (7D22-51)
  • Pipette tips (7D22-61)
  • Lancets (7D22-31)
  • EDTA Capillary Tubes (7D22-21)
Description For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens
Info Inverness Medical Professional Diagnostics
Customer Service: +44 (0)1234 835000
Web site: http://www.invernessmedical.com/

Related medicine products :

1. Determine HIV 1/2 - Serum & Plasma (20 Tests)
2. Determine HIV 1/2 - Whole blood (includes chase buffer) (20 Tests)
3. Determine HIV 1/2 - Serum & Plasma (100 Tests)
4. Determine HIV 1/2 - Whole blood (includes chase buffer) (100 Tests)
5. Determine HIV 1/2 - Serum & Plasma (CE marked) (100 Tests)
6. Determine HIV 1/2 - Serum & Plasma (CE marked) (20 Tests)
7. Determine Syphilis TP - Whole blood (CE marked) (Includes chase buffer)
8. Determine Syphilis TP - Serum & Plasma (CE marked)
9. Determine HBsAg - Whole blood (includes chase buffer)
10. VITROS® HBsAg Assay
11. Genetic Systems HBsAg EIA 3.0
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Research Reveals How Mitochondrial Gene Defects Impair Respiration Other Major Life Functions 58280 1Research Reveals How Mitochondrial Gene Defects Impair Respiration Other Major Life Functions 58280 2Research Reveals How Mitochondrial Gene Defects Impair Respiration Other Major Life Functions 58280 3Encouraging HIV AIDS Vaccine Trial Results Support GeoVax Labs Inc Strategy 14265 1Encouraging HIV AIDS Vaccine Trial Results Support GeoVax Labs Inc Strategy 14265 2Encouraging HIV AIDS Vaccine Trial Results Support GeoVax Labs Inc Strategy 14265 3Encouraging HIV AIDS Vaccine Trial Results Support GeoVax Labs Inc Strategy 14265 4Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 1Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 2Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 3Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 4Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 5Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 6Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 7Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 8Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 9